Bursch et al. dosed MCF-7 (estrogen dependent, ER+ breast cancer cell line) with various antiestrogen therapies and showed increased autophagosome formation, and theorized that endocrine therapies promote autophagy-mediated cell death (36). The gene discussed is ESR1; the disease is breast carcinoma.